Silk-based biospecimen stabilization for exposure assessment diagnostics
Award amount
$225,000Program and phase
SBIR · Phase IAward year
2015Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- VAXESS TECHNOLOGIES INC
- Proposal award date
- 2015-06-01
- Contract end date
- 2016-05-31
- UEI
- HNLJN8YZPVJ3
- Solicitation number
- ES14-005
- Topic code
- NIEHS
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of a Needle Free Microarray Patch for Delivery of a GLP-1 Receptor Agonist
- Microarray Patch for Broadly Protective Seasonal Influenza Vaccination
- SBIR Phase I: At home, single dose mRNA vaccine patch (COVID-19)
- Improved Influenza Vaccine Efficacy Through Infection Mimicry
- Improved Influenza Vaccine Efficacy Through Infection Mimicry
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Bioinspired Green Glycolipids as Fugitive Dust Mitigation Agents
- Supercritical Fluid Cartridges for Calibration of Air Pollution Sensors
- Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle interventions to lose weight and reduce EDC exposure in individuals with overweight/obesity
- High-Resolution Ground-Level AQ Monitoring System Using Hyper-local Low-cost Sensor Nodes and AI Forecasting
- Bringing PFAS Monitoring Home: An Integrated Magnetic Nanoparticle and Lateral Flow Assay System
Research funding history
11 SBIR/STTR records share this UEI (2015–2024). Reported award amounts total $9,792,329. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation